Hemostasis Today

Roberta Gualtierotti: Major Genomic Study Identifies Novel Fibromyalgia Risk Genes
Jul 31, 2026, 03:23

Roberta Gualtierotti: Major Genomic Study Identifies Novel Fibromyalgia Risk Genes

Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article by Isabel Kerrebijn et al, published in Nature Medicine, adding:

“The strongest association was with a coding variant in HTT, the causal gene for Huntington’s disease.

Gene prioritization implicated the HTT regulator GPR52, as well as diverse genes with neural roles, including DCC, DRD2/NCAM1, MDGA2 and CELF4.”

Title: The genetic architecture of fibromyalgia across 2.5 million individuals

Authors: Isabel Kerrebijn, Gyda Bjornsdottir, Keon Arbabi, Lea Urpa, Hele Haapaniemi, Gudmar Thorleifsson, Lilja Stefansdottir, Stephan Frangakis, Jesse Valliere, Lovemore Kunorozva, Erik Abner, Caleb Ji, Markus Kangur, Bitten Aagaard, Henning Bliddal, Søren Brunak, Mie T. Bruun, Maria Didriksen, Christian Erikstrup, Sarah Finer, Arni J. Geirsson, Daniel F. Gudbjartsson, Thomas F. Hansen, David van Heel, Ingileif Jonsdottir, Stacey Knight, Kirk U. Knowlton, Christina Mikkelsen, Lincoln D. Nadauld, Thorunn A. Olafsdottir, Sisse R. Ostrowski, Ole B. V. Pedersen, Saedis Saevarsdottir, Astros T. Skuladottir, Erik Sørensen, Hreinn Stefansson, Patrick Sulem, Olafur A. Sveinsson, Gudny E. Thorlacius, Unnur Thorsteinsdottir, Henrik Ullum, Arnor Vikingsson, Thomas M. Werge, Chronic Pain Genomics Consortium, FinnGen, DBDS Genomic Consortium, Estonian Biobank Research Team, Genes and Health Research Team, Richa Saxena, Kari Stefansson, Chad M. Brummett, Bente Glintborg, Daniel J. Clauw, Thorgeir E. Thorgeirsson, Frances M. K. Williams, Nasa Sinnott-Armstrong, Hanna M. Ollila, Michael Wainberg

Roberta Gualtierotti: Major Genomic Study Identifies Novel Fibromyalgia Risk Genes

Stay updated on all scientific advances with Hemostasis Today.